JASPER THERAPEUTICS INC's ticker is and the CUSIP is 471871103. A total of 24 filers reported holding JASPER THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $108,436 | -48.9% | 154,909 | 0.0% | 0.00% | – |
Q2 2023 | $212,225 | -24.5% | 154,909 | -0.2% | 0.00% | – |
Q1 2023 | $281,068 | +2612.2% | 155,286 | +623.6% | 0.00% | – |
Q4 2022 | $10,363 | -39.0% | 21,460 | 0.0% | 0.00% | – |
Q3 2022 | $17,000 | -58.5% | 21,460 | 0.0% | 0.00% | – |
Q2 2022 | $41,000 | -43.1% | 21,460 | +5.8% | 0.00% | – |
Q1 2022 | $72,000 | -54.7% | 20,289 | 0.0% | 0.00% | – |
Q4 2021 | $159,000 | – | 20,289 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Qiming U.S. Ventures Management, LLC | 5,852,982 | $20,778,000 | 19.52% |
Velan Capital Investment Management LP | 3,219,036 | $10,180,000 | 9.45% |
Abingworth LLP | 5,628,558 | $19,531,000 | 5.54% |
SECTORAL ASSET MANAGEMENT INC | 675,000 | $2,396,000 | 0.42% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 540,000 | $1,917,000 | 0.20% |
Vahanian & Associates Financial Planning Inc. | 10,000 | $36,000 | 0.08% |
Forefront Analytics, LLC | 32,550 | $118,000 | 0.04% |
Citadel Advisors | 2,994,580 | $10,631,000 | 0.00% |
FEDERATED HERMES, INC. | 251,697 | $894,000 | 0.00% |
Ionic Capital Management LLC | 100 | $0 | 0.00% |